Drug Facts Active Ingredient (In Each Tablet)
Meclizine HCl, USP 12.5 mg
The following Structured Product Label (SPL) was submitted to the FDA by Bluepoint Laboratories for the product Meclizine Hcl (NDC 68001-528). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding drug facts active ingredient (in each tablet), purpose, uses, warnings, when using this product, otc - pregnancy or breast feeding, keep out of reach of children., directions, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Meclizine HCl, USP 12.5 mg
Antiemetic
prevents and treats nausea, vomiting or dizziness associated with motion sickness.
Do not use in children under 12 years of age unless directed by a doctor.
Do not take this product, unless directed by a doctor, if you have
Do not take this product if you are
taking sedatives or tranquilizers,
without first consulting your doctor.
If pregnant or breast-feeding, ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).
| adults and children 12 years and over | take 2 or 4 tablets once daily or as directed by a doctor |
colloidal silicon dioxide, crospovidone, lactose monohydrate, magnesium stearate, microcrystalline cellulose
Call 1-844-474-7464 Monday to Friday 8 AM - 5 PM ET
NDC 68001-528-00
Meclizine Hydrochloride Tablets, USP
12.5 mg
100 Tablets
* Please review the disclaimer below.